午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Solifenacin Impurity
Solifenacin Impurity
  • Solifenacin Impurity
  • Solifenacin Impurity
  • Solifenacin Impurity
  • Solifenacin Impurity
  • Solifenacin Impurity

Solifenacin Impurity NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-06-20

Product Details

Product Name: Solifenacin Impurity CAS No.: 34286-16-3
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/06/20
Molecular formula: C10H15NO3

Solifenacin Impurity;34286-16-3

=Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Code:S003029

  • English Name:Solifenacin Impurity 29

  • English Alias:ethyl 3-oxoquinuclidine-2-carboxylate

  • CAS No.:34286-16-3

  • Molecular Formula:C??H??NO?

  • Molecular Weight:197.23

Advantages

  • High-Purity Guarantee:Confirmed by HPLC (≥99.0%) and verified through multiple methods including NMR (1H, 13C), HRMS, and elemental analysis, providing an accurate and reliable standard for Solifenacin impurity analysis.

  • Excellent Stability:Stable for 36 months under -20℃ light-protected and sealed storage. The degradation rate is less than 0.3% within 6 months in methanol - water mixture, meeting long-term experimental research and drug quality control requirements and ensuring stable data.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 29 in Solifenacin API and formulations. Strictly control the impurity content to meet ICH Q3A standards (single impurity limit ≤0.1%) and ensure drug quality and safety.

  • Process Optimization Research:Monitor the formation pathway of this impurity during Solifenacin synthesis. By adjusting parameters such as cyclization reaction temperature (e.g., 60 - 70℃), reaction time, and reactant ratio, the generation of impurities can be reduced by more than 30%.

  • Method Validation:As a standard for developing and validating impurity detection methods, it can verify the resolution (≥3.0) and limit of detection (0.01 ng/mL) of UPLC, ensuring the accuracy and sensitivity of the detection method.

Background Description

Solifenacin, a selective muscarinic M3 receptor antagonist, is mainly used for treating overactive bladder by inhibiting detrusor muscle contraction. Impurity 29, a process-related impurity in its synthesis, may originate from side reactions during quinuclidine construction or esterification. Its ester and carbonyl groups may affect drug solubility, metabolic stability, and efficacy. Since urological drugs are taken long-term, strict control of impurities is directly related to patient safety, making research on this impurity an important part of ensuring drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS technology, combined with a C18 column (1.7μm) and gradient elution with 0.1% formic acid - acetonitrile, achieves impurity separation within 5 minutes, with a detection limit as low as 0.003 ng/mL for high-precision trace impurity detection.

  • Formation Mechanism:Formed by the oxidation of quinuclidine derivatives with an oxidant (such as manganese dioxide), followed by esterification with ethanol under an acidic catalyst (such as p-toluenesulfonic acid). Optimizing the dosage of oxidant and catalyst and the reaction pH can effectively inhibit side reactions.

  • Safety Evaluation:In vitro cytotoxicity experiments show that the IC?? of this impurity against HEK293 cells is 185.6 μM (Solifenacin IC?? = 12.3 μM). Although the toxicity is lower than that of the main drug, its content in drugs still needs to be strictly controlled. Currently, long-term stability tests are being carried out to systematically study its degradation characteristics and potential risks under high temperature, high humidity, and light conditions.

NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 






Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$/
VIP5Y
RongNa Biotechnology Co.,Ltd
2025-04-29
$0.00/1g
VIP3Y
Hangzhou ICH Biofarm Co., Ltd
2023-07-05
$93.00/100mg
VIP5Y
TargetMol Chemicals Inc.
2025-07-16
INQUIRY